Showing results (1-10 of 239) with videos related to
Sort By:
Pageof 24
La Revue De Medecine Interne|January 1, 1996
[Dose expression of antineoplastic drugs]R Favre, F Duffaud, G ErardAnnales De Biologie Clinique|January 1, 1995
[Tests of micronucleus count in lymphocytes: a validation study]F Duffaud, R Favre, A BottaBulletin Du Cancer|September 30, 1998
[Importance of micronucleus tests in cultured binuclear T lymphocytes for the detection of genotoxic events in cancer patients]F Duffaud, T Orsière, L Digue, et al.Annales De Biologie Clinique|October 1, 1998
[Doxorubicin and cisplatin genotoxicity: search for a real indication using the micronucleus test]F Duffaud, T Orsière, M Baciuchka-Palmaro, et al.Mutation Research|February 19, 1999
Micronucleated lymphocyte rates from head-and-neck cancer patientsF Duffaud, T Orsière, L Digue, et al.Therapeutic Drug Monitoring|October 1, 1995
Dosage adjustment of high-dose methotrexate using Bayesian estimation: a comparative study of two different concentrations at the end of 8-h infusionsT Pignon, B Lacarelle, F Duffaud, et al.Mutagenesis|July 1, 1997
Comparison between micronucleated lymphocyte rates observed in healthy subjects and cancer patientsF Duffaud, T Orsière, P Villani, et al.Cancer Chemotherapy and Pharmacology|January 1, 1994
Pharmacokinetics of high-dose methotrexate in adult osteogenic sarcomaT Pignon, B Lacarelle, F Duffaud, et al.Cancer|January 21, 2000
Osteosarcomas of flat bones in adolescents and adultsF Duffaud, L Digue, M Baciuchka-Palmaro, et al.Journal of Clinical Pharmacy and Therapeutics|April 26, 2003
Population pharmacokinetics of cisplatin after 120-h infusion: application to routine adaptive control with feedbackS Monjanel-Mouterde, J Ciccolini, D Bagarry, et al.Pageof 24